Clinical trial
Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes
NCT05233592 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes
- Lead sponsor
- Johns Hopkins University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 8, 2022
- Completion date
- April 4, 2023
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 1, type 1 diabetes